Abstract
Sjögren’s syndrome (SS) is an immune system oral disorder that is characterized generally by dry mouth and eyes. In this review, SS classification, presentation and pathogenesis are briefly discussed. Moreover, the epidemiology of SS regarding sex, age and association with other complications are also presented. This review also addresses the interactions between endocrine axes and SS, and the important findings up to regarding hormone treatment of this syndrome. The main hormones discussed in this review includes Adrenocorticotropic hormone (ACTH), Follicle-stimulating hormone (FSH), Luteinizing hormone (LH), Thyroid-stimulating hormone (TSH), and prolactin.
Keywords: Antiphospholipid syndrome, dry eyes, hormones, hypothyroidisem, immune system, Sjögren's syndrome.
Current Pharmaceutical Design
Title:Influence of Hormones on Sjögren’s Syndrome
Volume: 24 Issue: 35
Author(s): Liu Yang, Wei Wei, Xi He, Yu Xie, Mohammad A. Kamal and Jiang Li*
Affiliation:
- Department of Prosthodontics, Dental Hospital, Jilin University, Changchun, Jilin 130021,China
Keywords: Antiphospholipid syndrome, dry eyes, hormones, hypothyroidisem, immune system, Sjögren's syndrome.
Abstract: Sjögren’s syndrome (SS) is an immune system oral disorder that is characterized generally by dry mouth and eyes. In this review, SS classification, presentation and pathogenesis are briefly discussed. Moreover, the epidemiology of SS regarding sex, age and association with other complications are also presented. This review also addresses the interactions between endocrine axes and SS, and the important findings up to regarding hormone treatment of this syndrome. The main hormones discussed in this review includes Adrenocorticotropic hormone (ACTH), Follicle-stimulating hormone (FSH), Luteinizing hormone (LH), Thyroid-stimulating hormone (TSH), and prolactin.
Export Options
About this article
Cite this article as:
Yang Liu , Wei Wei , He Xi, Xie Yu, Kamal A. Mohammad and Li Jiang*, Influence of Hormones on Sjögren’s Syndrome, Current Pharmaceutical Design 2018; 24 (35) . https://dx.doi.org/10.2174/1381612824666181010153536
DOI https://dx.doi.org/10.2174/1381612824666181010153536 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biomarkers Associated with Stroke Risk in Atrial Fibrillation
Current Medicinal Chemistry Co-Existence of Sarcoidosis and Sjögren’s Syndrome with Hypercalcemia and Renal Involvement: A Case Report and Literature Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Neurological Involvement as the Initial Manifestation in Primary Sjögren's Syndrome - A Case Report
Current Rheumatology Reviews History of Autoimmune Pancreatitis and Mikuliczs Disease
Current Immunology Reviews (Discontinued) Identification of Moesin as a Novel Autoantigen in Patients with Sjögren’s Syndrome
Protein & Peptide Letters Rheumatoid Arthritis Patients with Sjogrens Syndrome are More Prone to Depression than Patients with Rheumatoid Arthritis or Sjogrens Syndrome Alone
Current Rheumatology Reviews Pleural Involvement in Systemic Disorders
Current Drug Targets - Inflammation & Allergy Mikuliczs Disease and its Extraglandular Lesions
Current Immunology Reviews (Discontinued) Mesenchymal Stem Cell Therapy for Oral Inflammatory Diseases: Research Progress and Future Perspectives
Current Stem Cell Research & Therapy IgG4-Related Disease (IgG4+MOLPS) – Diagnostic Criteria and Diagnostic Problems
Current Immunology Reviews (Discontinued) TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders
Inflammation & Allergy - Drug Targets (Discontinued) From Molecular Mechanism to the Etiology of Sjogren Syndrome
Current Pharmaceutical Design Cardiovascular Disease in Primary Sjögren’s Syndrome
Reviews on Recent Clinical Trials Rituximab Therapy and Autoimmune Disease
Current Immunology Reviews (Discontinued) IL-27: Friend or Foe in the Autoimmune Diseases
Current Immunology Reviews (Discontinued) Chemokines in Rheumatic Diseases
Current Drug Targets B-Lymphocytes Govern the Pathogenesis of Sjogren's Syndrome
Current Pharmaceutical Biotechnology Sjogrens Syndrome and Lymphoma Development
Current Immunology Reviews (Discontinued) Selenium and Autoimmune Diseases: A Review Article
Current Rheumatology Reviews Substance P in Rheumatic Diseases
Current Rheumatology Reviews